Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

LA Jolla Pharma (LJPC)

LA Jolla Pharma (LJPC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 159,140
  • Shares Outstanding, K 27,157
  • Annual Sales, $ 10,060 K
  • Annual Income, $ -199,470 K
  • 60-Month Beta 2.07
  • Price/Sales 15.72
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.06
  • Number of Estimates 4
  • High Estimate -1.03
  • Low Estimate -1.09
  • Prior Year -1.73
  • Growth Rate Est. (year over year) +38.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.56 +2.45%
on 11/21/19
8.97 -36.50%
on 10/22/19
-2.95 (-34.15%)
since 10/21/19
3-Month
5.56 +2.45%
on 11/21/19
11.41 -50.08%
on 09/11/19
-4.61 (-44.75%)
since 08/21/19
52-Week
5.01 +13.69%
on 01/08/19
16.44 -65.35%
on 11/26/18
-9.85 (-63.37%)
since 11/21/18

Most Recent Stories

More News
La Jolla Pharm Set to Possibly Rebound After Yesterday's Selloff of 2.47%

La Jolla Pharm (NASDAQ:LJPC) traded in a range yesterday that spanned from a low of $5.56 to a high of $5.95. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $5.77...

LJPC : 5.67 (-3.24%)
La Jolla Pharmaceutical (LJPC) Reports Q3 Loss, Misses Revenue Estimates

La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of -0.93% and -18.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?...

LJPC : 5.67 (-3.24%)
La Jolla Pharmaceutical: 3Q Earnings Snapshot

SAN DIEGO (AP) _ La Jolla Pharmaceutical Co. (LJPC) on Tuesday reported a loss of $29.2 million in its third quarter.

LJPC : 5.67 (-3.24%)
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Progress

La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from...

LJPC : 5.67 (-3.24%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (AIMT , ARWR, LJPC , MRTX, AGIO )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

AIMT : 26.51 (+2.87%)
LJPC : 5.67 (-3.24%)
ARWR : 48.83 (+0.99%)
MRTX : 89.57 (-5.07%)
La Jolla Pharmaceutical Company to Present at the 21st Annual H.C. Wainwright Global Investment Conference

La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from...

LJPC : 5.67 (-3.24%)
La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA(TM) (angiotensin II)

La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from...

LJPC : 5.67 (-3.24%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (AMAG , LJPC , AMGN , AIMT , EPZM )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

AMAG : 9.93 (+1.02%)
AMGN : 227.94 (+1.08%)
LJPC : 5.67 (-3.24%)
La Jolla Pharmaceutical (LJPC) Reports Q2 Loss, Lags Revenue Estimates

La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of 0.00% and -1.04%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

LJPC : 5.67 (-3.24%)
La Jolla Pharmaceutical: 2Q Earnings Snapshot

SAN DIEGO (AP) _ La Jolla Pharmaceutical Co. (LJPC) on Thursday reported a loss of $30.4 million in its second quarter.

LJPC : 5.67 (-3.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade LJPC with:

Business Summary

LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases.

See More

Key Turning Points

2nd Resistance Point 6.23
1st Resistance Point 6.04
Last Price 5.67
1st Support Level 5.69
2nd Support Level 5.53

See More

52-Week High 16.44
Fibonacci 61.8% 12.07
Fibonacci 50% 10.73
Fibonacci 38.2% 9.38
Last Price 5.67
52-Week Low 5.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar